Vol 77, No 11 (2019)
Expert opinion
Published online: 2019-11-13

open access

Page views 894
Article views/downloads 852
Get Citation

Connect on Social Media

Connect on Social Media

Interventional closure of patent foramen ovale in prevention of thromboembolic events. Consensus document of the Association of Cardiovascular Interventions and the Section of Grown‑up Congenital Heart Disease of the Polish Cardiac Society

Aleksander Araszkiewicz, Stanisław Bartuś, Marcin Demkow, Marek Grygier, Zenon Huczek, Monika Komar, Radosław Pracoń, Tadeusz Przewłocki, Robert Sabiniewicz, Grzegorz Smolka, Maria Olszowska, Wojciech Wojakowski
Pubmed: 31723115
Kardiol Pol 2019;77(11):1094-1105.

Abstract

ABSTRACT The presence of patent foramen ovale (PFO) was found to be associated with a number of medical conditions, including embolic stroke and recurrent transient neurological defects. The closure of PFO remains controversial; however, in recently published guidelines from the European Association of Percutaneous Cardiovascular Interventions in collaboration with 7 other European societies, which extensively refer to the latest randomized clinical trials, it is explicitly recommended to perform percutaneous PFO closure in the prevention of recurrent thromboembolic events. In connection with the above facts and expected increasing number of PFO closure procedures, the joint expert group of the Association of Cardiovascular Interventions and the Grown‑Up Congenital Heart Disease Section of the Polish Cardiac Society developed the following consensus opinion in order to standardize the principles of diagnosis, indications, methods of performing procedures, and postoperative care in relation to Polish conditions and experiences.

Article available in PDF format

View PDF Download PDF file



Polish Heart Journal (Kardiologia Polska)